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Abstract 
 
1. We have investigated whether methylguanidine (MG), an uremic toxin, modulates the 
expression of the inducible nitric oxide synthase (iNOS) and nitric oxide (NO) release in vitro 
in LPS-induced J774 macrophages. 
2. Addition of MG (0.01-1mM) or L-NAME (0.01-1mM), 30 min before LPS challenge, 
inhibited significantly (37.77 % inhibition, P<0.001; n=12) but only at the highest 
concentration tested LPS-induced nitrite production. 
3.When J774 macrophages were pretreated with MG or L-NAME (0.01-1mM) 18h prior 
stimulation with LPS, MG significantly (P<0.001) inhibited, in a concentration related 
manner, LPS-stimulated nitrite production reducing nitrite levels by 40.26 % (n=12), 31.85 % 
(n=9) and 26.68 % (n=6)  for MG 1, 0.1 and 0.01 mM respectively. 
4. MG, added to the culture medium of J774 macrophages 24 h after LPS challenge, also 
reduced significantly and  in a concentration-related manner nitrite production inhibiting NO 
release by 50.0 % (P<0.001, n=32),  26.0 % (P<0.05, n=23) and 3.18 % for MG 1, 0.1 and 
0.01 mM respectively. In this condition when the culture medium was supplemented with L-
arginine (10mM; L-ARG) the inhibitory effect of MG (1mM) on nitrite production was  
reversed to 10.86 % significantly different (P<0.05) from MG-inhibitory effect observed in 
normal medium. 
5. Preincubation of cells with MG (1mM; 24 h) 30 min and 18 h prior to activation with LPS 
resulted in inhibited iNOS protein expression by 44.16±5.7 % (P<0.01; n=3) and 30.47±3.9 % 
(P<0.01; n=3). In the same conditions L-NAME (1mM) did not modify significantly iNOS 
expression. 
7. MG (1mM) or L-NAME (1mM) added to the culture medium 24 h after LPS challenge did 
not modify iNOS protein expression. 
8. Our results show that MG inhibited LPS-induced nitrite production in the murine 
macrophages cell line J774. This inhibitory effect could be partly due to the antagonistic 
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activity on iNOS protein that is reversed by L-Arg supplementation and partly related to the 
inhibitory effect on iNOS expression . 
9. Parallel experiments employing L-NAME (0.01-1 mM) have been carried out for 
comparison in all the three different experimental settings. Similar results on LPS-induced 
nitrite production but different results on iNOS expression have been obtained for L-NAME. 
 
Key words: macrophages; bacterial lipopolysaccharide; nitric oxide, inducible nitric oxide 
synthase, methylguanidine; L-arginine; L-NAME 
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Introduction 
It has been well established that an immunodeficient state often paradoxically coexists with 
signs of activation of immune system in patients with chronic renal failure (CRF) 
(Deschamps–Lastscha, 1993). While chronic activation of monocytes has been recognized as 
a key factor responsible for the immunological disorders, the existing immunodeficiency may 
reflect inhibition of nitric oxide (NO) synthesis normally induced in macrophages as in part 
responsible of the host defense mechanism. More recently Le Meur and coworkers (1996) 
suggested the possibility that CRF-associated-immunodeficiency could be linked to multiple 
and complexes alterations of cytokine network and that target cells such as monocytes, T or B 
lymphocytes, fibroblasts and endothelial cells may be involved. In this disease chronic 
activation of monocyte functions has been recognized as a key factor responsible for 
immunological disorders associated to CRF that is accentuated rather than corrected by 
replacement dialysis therapy (Kawano et al., 1993; Kelly, 1994; Deenitchina et al., 1995). In 
1975 Jones and Burnett hypothesized that high blood concentration of various endogenous 
nitrogen compounds may be responsible of uraemic symptoms and immunodisfunctions. In 
1990 Yokozawa and coworkers and more recently Mendes-Ribeiro (1996) demonstrated that 
uraemia is often accompained by accumulation of L-arginine analogue NG-monomethyl-L-
arginine, methylguanidine (MG) and its precursor creatinine. These results have been recently 
clarified by Aucella and coworkers (1998) who indicated that there are two key factors 
responsible for the different cytokine release: one is the different absorption of inflammatory 
mediators on the dialysis membrane surface and another one could be related to the different 
sterilization method used for haemodialysis membranes that may be responsible for the higher 
serum levels of monokines, including TNFα, in patients with CRF in haemodialysis (Kawano 
et al., 1993). In this regard we have previously demonstrated that methylguanidine (MG), an 
uremic toxin, inhibits NO production of both the constitutive and inducible isoforms of NO 
synthase (Sorrentino et al., 1997), that in vivo pretreatments in rats with MG, simulating a 
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pattern similar to the uremic conditions, significantly inhibited serum levels of TNF-α 
measured in vivo 2h after LPS challenge and also in vitro MG (1mM) reduced significantly 
TNF-α released by LPS-induced J774  (Autore et al., 1999) 
In order to examine whether the uraemic toxin MG could modulate iNOS activity and/or 
iNOS expression and whether these effects could be related to the time or concentration of 
MG added to J774 medium, in this study we have examined in vitro the ability of MG to 
influence iNOS expression and/or NO release in the murine macrophage cell line J774 
stimulated with LPS. Parallel experiments employing L-NAME were also carried out for 
comparison. 
 
METHODS 
Cell culture  
Murine macrophage cell line, J774, was maintained in continous culture in DMEM 
supplemented with NaHCO3 (42 mM), penicillin (100 units ml-1), streptomycin (100 units ml-
1), glutamine (2 mM) and foetal calf serum (10 %). Monolayers of cells were routinely 
harvested by gentle scraping with a Teflon cell-scraper, diluted 1:10 in fresh medium and 
cultured to confluency at 37 °C 95 % air and 5 % CO2 atmosphere.  
Determination of the cytotoxic activity 
J774 (3.5×104) were plated on 96-well microtiter plates and allowed to adhere at 37°C in 5 % 
CO2, 95 % air for 2 h. Thereafter the medium was replaced with 50 μl of fresh medium and 
75 μl aliquot of 1:2 v v-1 serial dilution of MG (0.01-1 mM, dissolved in culture medium) was 
added and the cells incubated for 24, 48, 72 h. The cells viability was assessed accordingly to 
the method of Mosman, 1983.  Briefly, 25μl of 3-(4,5-dimethyltiazol-2yl)-2,5-phenyl-2H-
tetrazolium bromide] (MTT, 5 mg ml-1) was added and the cells were incubated for additional 
3 h. Following this time the cells were lysed and the dark blue crystals solubilized with 100 μl 
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of a solution containing 50 % (v:v) N,N-dimethilformamide, 20 % (w:v), SDS (sodium 
dodecyl sulphate) with an adjusted pH of 4.5 (Opipari et al., 1992). The optical density (OD) 
of each well was measured with a microplate spectrophotometer equipped with a 620 nm 
filter. The viability of J774 cell line in response to treatment with compounds was calculated 
as: % dead cell = 100-(OD treated/ OD control) ×100.  
Analysis of nitrite production 
Prior to each experiment, harvested cells were plated at a seeding density of 2.5x105 cells ml-1  
.Cells were activated with LPS (6x103units ml-1) alone or in combination with MG (0.01-1 
mM) or L-NAME (0.01-1 mM), used as reference drug. In our studies MG and L-NAME 
were also added to the culture medium of J774  30 min or 18 h before and simultaneously 
with LPS. 
The culture medium was replaced with fresh DMEM plus MG or L-NAME after each 
different incubation time. NO release was determined 24 h after LPS-activated J774 by 
measuring accumulated nitrite levels in the culture medium by the Griess reaction (Green et 
al., 1982) and expressed as μM NO2- released in medium from 2.5x105 cells ml-1 released in 
medium 24 h after  LPS challenge or as percentage inhibition calculated versus  LPS alone.   
Western Blot analysis for iNOS expression 
Confluent monolayers of J774 in well culture plates (1.5x106 cells/well) were preincubated 
with MG (1mM) or L-NAME (1mM) for 30 min or 18 h respectively and then incubated with 
either DMEM alone or DMEM containing LPS (6x103 u ml-1) alone or in combination with 
MG (1mM) or L-NAME (1mM). After 24 h incubation with LPS, cells were scraped off, 
washed with ice-cold phosphate buffered saline (PBS) [(mM): 140 NaCl, 2.7 KCl, 8.1 Na2 
HPO4, 1.5 K2HPO4 (pH 7.4)], and harvested by centrifugation (5000 g, 10 min at 4°C) and 
resuspended in a buffer containing 20 mM TRIS HCl (pH 7.5), 1 mM Na+ orthovanadate, 1 
mM phenylmethylsulfonyl fluoride, 10 μg ml-1 leupeptin, 10 mM NaF, 150 mM NaCl, 10 mg 
ml-1 tripsin inhibitor and 1% Nonidet P 40. Protein concentration was estimated by the Bio-
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Rad protein assay using bovine serum albumin as standard. Equal amounts of protein (70 µg) 
of cell lysates were dissolved in Laemmli’s sample buffer, boiled, and run on a SDS-PAGE 
minigel (8 % polyacrylamide) and transferred for 40 minutes at 5 mA cm2 into 0.45 µm 
hybond polyvinyldeme difluoride membrane. Membranes were blocked for 40 minutes in 
PBS 1× containing 5 % (w v-1) non fat milk and subsequently probed overnight at 4 °C with 
mouse monoclonal anti-iNOS antibody (1:10.000 dilution in PBS 1× containing 5 % w v-1 
non fat milk and 0.1 % Tween-20). Blots were then incubated, after four washes in PBS 1× 
containing 5% w/v non fat milk and 1% Tween 20, with horseradish peroxidase conjugated 
goat anti-mouse IgG (1:5.000) for 1 h at room temperature. Immunoreactive bands were 
visualized using ECL detection system according to the manufacturer’s instructions and 
exposed to Kodak X-Omat film. The protein bands of iNOS on X ray film were quantified by 
scanning densitometry (Imaging Densitometer GS-700 BIO-RAD U.S.A.) and the data are 
expressed as a percentage of the values obtained from samples containing cells with LPS 
alone. 
Materials 
Escherichia coli lipopolysaccharide (activity 6x106 u mg-1) was obtained from Fluka (Italia). 
Methylguanidine, NG-nitro-L-arginine methylester, [3-(4,5-dimethyl-thiazolyl-2yl) 2.5 
diphenyl tetrazolium bromide], PBS, NaCl, KCl, Na2HPO4, K2HPO4 ,Tris HCl, Na+ 
orthovanadate, phenylmethylsulfonylfluoride, bovine serum albumin were obtained from 
Sigma Chemical Co., Italy. Kodak X-Omat film, Hybond polyvinyldeme difluoride 
membrane, ECL detection system, Hybond polyvinyldeme difluoride membrane were from 
Amersham Life Science Ltd Buckinghamshire (U.K.).  Lleupeptin, tripsin, Nonidet, Biorad 
reactive, Laemmli’s sample buffer, polyacrylamide, non fat milk, Tween 20, horseradish 
peroxidase conjugated goat anti-mouse  
Mouse monoclonal antibody for inducible nitric oxide synthase was from Jackson (U.K.). 
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Dulbecco’s Modified Eagle’s Medium, penicillin/streptomycin, HEPES, glutamine, Foetal 
calf serum and horse serum were from Hy Clone ( Euroclone, U.K.). 
Statistics 
 
Data are expressed forn nitrite production as μM NO2 – released in medium from 2.5x105 cells 
ml-1.  For Western Blot anlysis data are expressed as percentage of inhibition calculated 
versus LPS alone. All values are means±s.e.mean of measurements in at least three different 
experiments with five replicates in each. Prism software version 2.01, GraphPad Inc.was used 
to perform statistical analysis. Comparisons were made using the one way ANOVA or using 
unpaired Student’s t-test. The level of statistical difference was defined as P<0.05. 
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RESULTS 
Inhibition of nitrite production by MG or L-NAME preincubated with cells  30 min  or 18 h 
before LPS challenge 
NO production in J774 cells incubated for 24 hours with LPS (6x103 u ml-1; 24 h) was 
significantly (P<0.0001) increased from a basal value of untreated cells of 0.05±0.03 µM to 
15.98± 0.8 µM 24 h-1 (n=36). 
MG added to the culture medium of incubation in a range from 0.01-1 mM inhibited NO 
formation. As shown in figure 1a LPS-stimulated J774 released 15.33±1.02  μmol l-1 NO2-  
(n=18) in the medium. MG, added to the culture medium 30 min before and simultaneously to 
LPS, only at the highest concentration  (1 mM) significantly inhibited NO release (P<0.001; 
37.77 %; Fig.1a). When MG (0.01-1 mM ) was added to the culture medium 18 h before and 
simultaneously to LPS reduced significantly (P<0.001) and in a concentration-dependent 
manner LPS-induced NO production giving rise to 40.26 % inhibition , 1mM; 31.85 % 
inhibition, 0.1 mM; 26.68 % inhibition, 0.01 mM respectively with P<0.001; Figure 2a). 
Parallel experiments were carried out with a well known NO synthase inhibitor, L-NAME. 
Results obtained with MG were comparable to those obtained with L-NAME (0.01-1 mmol l-
1) both when incubated for 30 min than for 18 h before LPS challenge ( Figure 1b and 2b).  
 
Effect of MG and L-NAME on NO release  from already expressed iNOS 
In previous experiments MG was added before any expression of iNOS; in another set of 
experiments J774 macrophages were stimulated with LPS (6x103 u ml-1) and 24 h later the 
medium was replaced with MG- or L-NAME-medicated medium  (0.01-1 mmol l-1) and the 
incubation was continued for further 24 h.  After the first incubation NO released in the 
medium was 14.69±0.61 μmol l-1, while NO production in the second incubation (24 h) was 
5.34±0.37 (n=52).  MG (0.01-1 mM), added 24 h after LPS challenge, markedly and 
significantly (P<0.001) reduced NO release both at the highest concentration (50 % inhibition, 
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P<0.001) than at lower concentration 0.1 mM ( 26 % inhibition , P<0.05, Figure 3a). Similar 
results have been obtained with L-NAME (0.01-0.1 mM), added 24 h after LPS addition. In 
this condition L-NAME decreased significantly and in a concentration related manner NO 
release by LPS-stimulated J774  (Figure 3b.). 
In this experimental condition L-ARG (10mM) supplementation significantly (P<0.05) 
reversed both MG than L-NAME inhibitory effect on NO release. In fact MG (1mM) added to 
the culture medium of LPS-stimulated-J774 24 h after LPS challenge gives rise to 50.0±9.0 % 
(P<0.001) inhibition in normal medium This inhibitory effect is significantly reversed in 
medium containing  L-ARG (10mM) to 10.86±1.8  % inhibition) that is significantly different 
(P<0.05) from  MG inhibitory effect (Figure 3a). Similar results have been obtained for L-
NAME (1mM). L-NAME in normal medium gives rise to a significant inhibition (64.79±2.8 
% with P<0.001 versus LPS) of NO release. This  inhibitory effect is significantly reversed 
with L-ARG (10 mM) to 24.11±5.3 % that is significantly (P<0.001) different from L-NAME 
inhibitory effect (Figure 3b.) 
 
Western Blot analysis for iNOS expression 
To determine whether the inhibitory effect caused by MG on NO released by LPS-stimulated 
J774 could also be due  to the inhibition of iNOS expression, Western Blot analysis was 
carried out on whole cell lysates using a monoclonal antibody for murine iNOS. In lysates 
from LPS-stimulated (6x103 u ml-1 24 h-1) but not from unstimulated cells the iNOS antibody  
recognised  as a single 130 kDa protein band which migrated at a molecular weght of 130 
kDa (Figure 4a. and Figure 5a) 
The level  of iNOS protein was markedly attenuated in lysates from  J774 cells preincubated  
with MG (1mM) or L-NAME (1mM) 30 min before and  then activated with LPS plus MG 
(1mM) or L-NAME (1mM).  MG, but not L-NAME, added to the culture medium only 30 
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min before LPS challenge, significantly reduced iNOS expression ( 44.16± 7.9 % inhibition ; 
n=3; P<0.05,Figure 4b.). A representative blot from these experiments is shown in Figure 4a.  
Similar results have been obtained when MG (1mM) or L-NAME (1mM) was preincubated 
with J774 18 h before LPS challenge. The level of iNOS protein was markedly and 
significantly  attenuated also in lysates from  J774 cells preincubated  with MG (1mM) or L-
NAME (1mM) 18 h  before and  then activated with LPS plus MG (1mM) or L-NAME 
(1mM).  In this experimental setting MG, but not L-NAME, significantly reduced iNOS 
expression  (30.47±3.9 % inhibition; n=3; P<0.01, Figure 5b). A representative blot from 
these experiments is shown in Figure 5a. 
The effect of MG on iNOS expression has also been observed incubating LPS-induced J774 
with MG or L-NAME (1mM) added 24 hours after LPS challenge. In this experimental 
setting both MG and L-NAME did not influence significantly iNOS. 
In all the different experimental settings MG (0.01-1 mM) or L-NAME (0.01-1 mM) did not 
affect significantly mitochondrial reduction of MTT to formazan (data not shown) both when 
incubated for 30 min, 18 h before LPS challenge and or 24 after LPS suggesting  that these 
compounds at the concentration tested are not cytotoxic to J774 cells even at the highest 
concentration used (1 mM). 
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DISCUSSION 
The present study demonstrates that preincubation of J774 macrophages with MG 
significantly affected LPS-induced nitrite production. Its inhibitory effect is both time- and 
concentration-dependent.. The maximal response was obtained following 18 h pretreatment of 
cells with 1 mM MG prior activation with LPS.  Although addition of MG only for 30 min 
before LPS challenge also inhibited accumulated nitrite levels, the inhibition was relatively 
less compared to responses produced after 18 h preincubation because MG, preincubated for 
30 min before LPS activation, was effective only at the highest concentration used (1 mM). 
On the other hand its inhibitory effect was effective still at 0.01-0.1 mM, when MG was 
added to J774 medium 18 h before LPS challenge, this effect is concentration dependent and 
appears to involve also regulation of iNOS expression at the molecular levels resulting in 
inhibited enzyme protein expression and thus NO production.  These findings suggest that 
MG could act with a dual mechanism of action on NO release. One mechanism may be 
directly linked to the inhibition iNOS expression, another one may be related to capability of 
MG to act as iNOS antagonist. 
Induction of iNOS is a time-dependent process requiring de novo protein synthesis. Enzyme 
expression is detected after about 6 h from LPS activation of cells, reaching a maximum at 12 
h and is maintained over aperiod of 24-48 h (Assreuy et al., 1993). Thus the fact that the 
addition of MG just 30 min before LPS challenge significantly inhibited iNOS expression and 
NO release strongly suggest that all these effects may be linked  to the inhibitory effect at 
certain upstream events probably associated with induction of the enzyme such as TNF-α 
release. In fact, Western blot analysis of lysates obtained from cells activated in the presence 
of LPS alone or in combination with MG showed that LPS-induced iNOS expression was 
significantly inhibited in the presence of MG, probably indicating decreased iNOS gene 
transcription and/or mRNA stability. 
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A growing body of evidence suggests that NO may be involved in the inflammatory 
processes, such as host defence mechanisms, induced by TNF-α (Moncada et al., 1991). NO 
is generated in macrophages by an inducible, calcium independent isoform of iNOS that is 
expressed to a significant level following stimulation with phlogogenic agents, as LPS 
(Moncada et al., 1991) and/or cytokines, including TNF-α ( Drapier et al.,1988; Chester et al., 
1998). 
TNF-α is an extremely potent peptide cytokine which serves as an endogenous mediator of 
inflammation and as an important factor in host defence functions (Berczi et al., 1996). It is 
not generally thought to be produced costitutively by normal cells, but rather to be induced by 
invasive stimuli in the setting of infectious diseases.  In this role, macrophages and monocytes 
are thought to be the cells which contribute most to the local and systemic TNF-α release in 
response to bacterial, viral and parasitic organisms and products. The consequences of 
endogenous TNF-α can be either beneficial or life threatening depending on the amount, time 
course and distribution of released cytokine.  
In this study we have simulated in vitro a pattern similar to the uremic conditions by 
incubating J774-macrophages for 30 min or 18 h in medium containing high concentrations of 
MG (1mM) and then we have stimulated J774 macrophages with LPS in presence of  MG or 
L-NAME. In the experimental setting in which MG was added to J774 medium 18 h before 
LPS challenge, we have previously demonstrated (Autore et al., 1999) that, in this condition, 
MG inhibits  in vitro TNF-α release, measured 3 h after LPS activation. In this paper we also 
demonstrated that MG is able to inhibit not only NO release but also iNOS expression. In the 
same experimental conditions L-NAME showed almost the same inhibitory effect, compared 
to MG effect, on TNF-α and NO release while did not show any significant inhibitory effect  
on iNOS expression. Similar results have been obtained by  Deakin (1995) and Ruetten & 
Thiemmermann (1996) with aminoguanidine (AMG).  In their papers they have demostrated 
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that the immunological stimulated TNF-α release is markedly attenuated by nitric oxide 
inhibitors (Deakin et al., 1995) and by AMG (Ruetten & Thiemmermann, 1996), an 
endogenous compound which is  structurally-tightly-linked to MG.  
Previously we have demonstrated (Sorrentino et al., 1997) the ability of MG to link and to 
inhibit a semicrude preparation of both constitutive (neuronal and endothelial)  and inducible 
isoforms (macrophagic) of NOS but the relevance of the present paper regarded the ability of  
MG to regulate not only iNOS activity but although iNOS expression and on the basis of our 
previous results obtained both in vitro in LPS-treated-J774 macrophages than in vivo in LPS-
treated rats we could hypothesize that the effects observed could be due or tightly linked to 
the inhibition of TNF-α release (Autore et al.,1999). 
The ability of MG to inhibit iNOS expression and/or NO production may have significant 
implications in the pathogenesis of CRF where it has been reported that these patients often 
present an immunodeficient state that paradoxically coexists with signs of activation of 
immune system cells. Moreover, this is accentuated rather than corrected by replacement 
dialysis therapy (Deschamps-Latscha, 1993; Kelly, 1994; Deenitchina et al., 1995).  It is 
obvious that MG concentration in CRF patients could be quite different from the 
concentration used in our experimental model. Indeed, plasma concentration of MG in CRF 
patients have been calculated at around 27 µM (Orita et al., 1981). It is worth noting, however 
that MG can accumulate intracellularly, reaching concentrations which are 7 fold higher than 
those found in serum (Orita et al., 1981). 
In summary our results indicate that high concentration of MG could interfere not only in 
inhibiting iNOS activity but also in inhibiting iNOS expression. The ability of MG to inhibit 
NO release and iNOS expression may have significant implications in the pathogenesis of 
CRF where it has been reported that patients often present an immunodeficient state 
paradoxically coexisting with signs of activation of immune system cells. In conclusion our 
results strongly demonstrate that MG is a potent modulator of NO release and that its 
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inhibitory effect is not only due to a competitive antagonism of iNOS but also to an inhibitory 
activity on iNOS expression. These effects together with the ability of MG to inhibit TNFα 
release, as demonstrated in our previous study (Autore et al., 1999), could, at least in part, 
account for the immunodisfunction associated to CRF 
The relevance of these results is that in CRF patients the presence of high serum 
concentration of MG could interfere with NOS inhibitory activity (Sorrentino et al., 1997) and 
/or in cytokine network not only trough reduction of TNFα release (Autore et al., 1999) but 
also in inhibiting iNOS expression. This study points out a possible pathophysiological role 
for iNOS activity and expression in immunodisfuntions of haemodialitic patients where 
elevation of iNOS expression could be considered a physiological response to invasive stimuli 
that is drastically reduced when high concentrations of the uremic catabolyte, MG, are present 
in the blood. 
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Fig 1 (a, b). Concentration-dependent effect of LPS-induced nitrite production in J774 
macrophages by MG (1a) and L-NAME (1b). Cells were incubated with LPS (6x103 u ml-1) 
alone (control) or in combination with MG (0.01-1mM) or L-NAME (0.01-1 mM) added 
simoultaneously and 30 min before LPS challenge. Accumulated nitrite in the culture 
medium was determined 24 h after LPS addition by the Griess reaction.  Results are expressed 
as μmol l –1 NO2- (basal LPS levels were 15.33±1.02 μM NO2- 24 h -1) and values are the 
mean±s.e.m. of at least 3-6 independent experiments with 5 replicates in each. *** Denotes 
values significantly different from control at P<0.001. 
 
Fig 2 (a,b). Concentration-dependent inhibition of LPS-induced nitrite production in J774 
macrophages by MG and L-NAME. Cells were incubated with LPS (6x103 u ml-1) alone 
(control) or in combination with MG (0.01-1mM) or L-NAME (0.01-1 mM) added 
simoultaneously and 18 h before LPS challenge. Accumulated nitrite in the culture medium 
was determined 24 h after LPS addition by the Griess reaction. Results are expressed as μmol 
l –1 NO2- (basal LPS levels were 16.64±0.58 μM NO2- 24 h -1) and values are the mean±s.e.m. 
of at least 3-6 independent experiments with 5 replicates in each. *** Denotes values 
significantly different from control at P<0.001, * P<0.05. 
 
Fig 3 (a,b). Concentration-dependent inhibition of LPS-induced nitrite production in J774 
macrophages by MG or L-NAME, added 24 h after LPS challenge, and reversal inhibition of 
LPS-induced nitrite production in J774 macrophages by MG or L-NAME with L-ARG 
supplementation (10mM). Cells were incubated with LPS (6x103 u ml-1) alone (control) or in 
combination with MG (0.01-1 mM) or L-NAME (0.01-1 mM) with or without L-ARG 
(10mM) added 24 h after  LPS challenge. The effect of MG or L-NAME on accumulated 
nitrite in the culture medium was determined 48 h after LPS addition by the Griess reaction. 
Results are expressed as μmol l –1 NO2- and values are the mean±s.e.m. of at least 3-6 
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independent experiments with 3 replicates in each *** Denotes values significantly different 
from control at P<0.001, * P<0.05 
 
FIGURE  4. (a,b) Western blot analysis of inducible NO synthase in J774 cells. Lysates (70 
µg protein) from untreated cells (c) and from cells preincubated with MG or L-NAME (1mM) 
for 30 min (a,b) before LPS and  reincubated with LPS (6x103 u ml-1; 24 h) alone or in 
combination with either MG (1mM) or L-NAME  (1mM) were separated by SDS-PAGE, 
transferred to a nitrocellulose and blotted with a mouse monoclonal anti-iNOS antibody. The 
blot is representative of 3 independent experiments. (a) A representative blot from these 
experiments (b) Relative intensity of iNOS protein bands quantitated by scanning 
densitometry. Data are expressed as percentage of inhibition calculated versus LPS alone.  
 
FIGURE  5. (a,b) Western blot analysis of inducible NO synthase in J774 cells. Lysates (70 
µg protein) from untreated cells (c) and from cells preincubated with MG or L-NAME (1mM) 
for 18 h  before LPS and  reincubated with LPS (6x103 u ml-1; 24 h-1 )alone or in combination 
with either MG (1mM) or L-NAME  (1mM) were separated by SDS-PAGE, transferred to a 
nitrocellulose and blotted with a mouse monoclonal anti-iNOS antibody. These blots are 
representative of 3 independent experiments. (a) A representative blot from these experiments 
(b) Relative intensity of iNOS protein bands quantitated by scanning densitometry. Data are 
expressed as percentage of inhibition calculated versus LPS alone.  
Autore et al. 20 
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